| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.0M | — | +0.0% |
| R&D Expense | $60.4M | — | +73.1% |
| SG&A Expense | $16.9M | — | +36.2% |
| Operating Income | -$77.3M | — | -107.2% |
| Interest Expense | $368K | — | — |
| Pre-tax Income | -$81.0M | — | -139.8% |
| Income Tax | -$205K | — | +0.0% |
| Net Income | -$81.0M | — | -141.2% |
| EPS (Basic) | -$1.46 | — | -82.5% |
| EPS (Diluted) | -$1.46 | — | -82.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $500.2M | +352.1% | +154.5% |
| Short-term Investments | $217.0M | -6.7% | +87.3% |
| Current Assets | $730.2M | +107.9% | +129.8% |
| Total Assets | $747.7M | +94.9% | +124.0% |
| Current Liabilities | $61.2M | -2.4% | +24.5% |
| Total Liabilities | $411.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$75.2M | — | -103.0% |
| Capital Expenditures | $2K | — | -88.9% |
| Investing Cash Flow | $31.6M | — | +136.6% |
| Financing Cash Flow | $433.5M | — | — |
| Free Cash Flow | -$75.2M | — | -102.9% |
| +732.9% |
| Stockholders' Equity | $335.8M | +38.7% | +18.1% |